This inventor holds 2 USPTO granted patents. Top assignees: National Institute of Health and Medical Research, Societe Civile Bioprojet, Université De Caen. Active years: 1987-1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,853 
2 out of 20 
1 out of 3 Years Active: 1987-1994
Title: Jean-Charles M. Lancelot: Innovator in Cerebral Histamine Research
Introduction
Jean-Charles M. Lancelot is an accomplished inventor based in Tour en Bessin, France. He is recognized for his contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that influence cerebral histamine levels. With two patents under his name, Lancelot has made significant strides that could benefit neurological research and treatment.
Latest Patents
Lancelot's latest patents focus on a class of compounds known as 4-(4-imidazolyl) piperidines, which are substituted at position 1. These compounds are defined by intricate chemical formulas wherein R1 can represent various groups including hydrogen, and R can denote aliphatic groups or secondary amine groups. His work on these compounds is essential for controlling the release and renewal rate of cerebral histamine, which has implications for various neurological conditions.
Career Highlights
Throughout his career, Jean-Charles M. Lancelot has been associated with notable organizations such as Société Civile Bioprojet and the National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale). His innovative research has garnered attention in the scientific community and adds value to the discoveries related to cerebral functions.
Collaborations
Lancelot has collaborated with esteemed colleagues including Jean-Michel Arrang and Jeanne-Marie Lecomte. Together, they have pushed the boundaries of research in their field, exploring avenues that may enhance our understanding of neurological mechanisms.
Conclusion
In summary, Jean-Charles M. Lancelot's contributions to innovation in pharmaceutical chemistry have positioned him as a vital figure in cerebral histamine research. His patents reflect a commitment to enhancing medical understanding and improving therapeutic options in neurology. As he continues his work, the scientific community eagerly anticipates further advancements stemming from his innovative spirit.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile